Transcriptional profiling of samples from patients with many different cancer types, including glioblastoma, pancreatic cancer, breast cancer, ovarian cancer, CRC, and NSCLC, revealed that cancer patients with mesenchymal subtypes have high expression of TGFβ target genes and that this correlates with poor prognosis. Here, TGFB1 is linked to colorectal carcinoma.